Literature DB >> 8554976

Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.

E R Cameron1, M Campbell, K Blyth, S A Argyle, L Keanie, J C Neil, D E Onions.   

Abstract

A role for antigen stimulation in lymphoid neoplasia has been postulated and is supported by indirect evidence that suggests that the interaction of antigen with both T cells and B cells may constitute an epigenetic event that can contribute to tumour induction or tumour progression. Using myc-bearing transgenic mice that develop mainly clonal T-cell lymphomas we have investigated the possibility that endogenous antigen-mediated clonal deletion might be overridden in tumorigenesis. CD2-myc transgenic mice were backcrossed on to a CBA/Ca background to ensure Mtv-mediated deletion of V beta 11-expressing T cells in the resultant offspring. Lymphomas arising from these mice were subsequently screened for V beta 11 expression. There was a clear correlation between the age at which mice developed neoplasia and the tumour phenotype. Mice with CD4- CD8+ tumours succumbed to thymic lymphoma at a significantly younger age than mice developing CD4+ CD8+ tumours. A small number of tumours consisted of the 'forbidden' V beta 11 phenotype, showing that cells vulnerable to transformation could escape negative selection. The majority of the V beta 11-positive tumours were CD4- CD8+ and were only observed in mice showing clinical evidence of tumour development at a relatively young age. The phenotype of these cells and the age at which tumours arose suggests that T cells escaping tolerance may be susceptible to transformation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8554976      PMCID: PMC2074291          DOI: 10.1038/bjc.1996.3

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Neonatal thymectomy results in a repertoire enriched in T cells deleted in adult thymus.

Authors:  H Smith; I M Chen; R Kubo; K S Tung
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

2.  A nondeletional mechanism of thymic self tolerance.

Authors:  F Ramsdell; T Lantz; B J Fowlkes
Journal:  Science       Date:  1989-11-24       Impact factor: 47.728

3.  Retroviral transduction of T-cell antigen receptor beta-chain and myc genes.

Authors:  R Fulton; D Forrest; R McFarlane; D Onions; J C Neil
Journal:  Nature       Date:  1987 Mar 12-18       Impact factor: 49.962

4.  Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas.

Authors:  G Dighiero; S Hart; A Lim; L Borche; R Levy; R A Miller
Journal:  Blood       Date:  1991-08-01       Impact factor: 22.113

5.  A role for clonal inactivation in T cell tolerance to Mls-1a.

Authors:  M A Blackman; H G Burgert; H Gerhard-Burgert; D L Woodland; E Palmer; J W Kappler; P Marrack
Journal:  Nature       Date:  1990-06-07       Impact factor: 49.962

6.  Clonal anergy induced in mature V beta 6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells.

Authors:  H G Rammensee; R Kroschewski; B Frangoulis
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

7.  Interleukin 2 abrogates the nonresponsive state of T cells expressing a forbidden T cell receptor repertoire and induces autoimmune disease in neonatally thymectomized mice.

Authors:  J L Andreu-Sánchez; I M Moreno de Alborán; M A Marcos; A Sánchez-Movilla; C Martínez-A; G Kroemer
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

8.  Postnatal disappearance of self-reactive (V beta 6+) cells from the thymus of Mlsa mice. Implications for T cell development and autoimmunity.

Authors:  R Schneider; R K Lees; T Pedrazzini; R M Zinkernagel; H Hengartner; H R MacDonald
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

9.  Failure of clonal deletion in neonatally thymectomized mice: tolerance is preserved through clonal anergy.

Authors:  L A Jones; L T Chin; G R Merriam; L M Nelson; A M Kruisbeck
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

10.  Response of mature unprimed CD8+ T cells to Mlsa determinants.

Authors:  S R Webb; J Sprent
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more
  3 in total

1.  Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.

Authors:  Shala Dezfouli; Antony Bakke; Jie Huang; Anthony Wynshaw-Boris; Peter J Hurlin
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

2.  Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations.

Authors:  Kimberly G Laffey; Robert J Stiles; Melissa J Ludescher; Tessa R Davis; Shariq S Khwaja; Richard J Bram; Peter J Wettstein; Venkataraman Ramachandran; Christopher A Parks; Edwin E Reyes; Alejandro Ferrer; Jenna M Canfield; Cory E Johnson; Richard D Hammer; Diana Gil; Adam G Schrum
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-29       Impact factor: 12.779

3.  Skewed T-cell receptor Vbeta8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development?

Authors:  G Webster; D E Onions; J C Neil; E R Cameron
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.